Table 6.
Length-Amph-AMP * | Table- Peptide # |
CPP | Anti- Microbial & |
Anti- Cancer & |
Anti- Viral & |
Anti- Fung & |
Anti- Inflamm. $ |
Sum/6 | Rank † | Hemol. Probab. | Tox. Score | Reward Low tox. | Total Score § | Overall Rank |
CPP Part |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
25-αd-temp V1R9 | T3-37 | 0.97/H | 0.955 | 0.965 | 1.00 | 0.975 | 0.997 | 0.9869 | 1 | 0.130 | −1.27 | 0.570 | 0.92734 | 1st | WFS6R7 |
31-αtαd-temp R9R14 | T4-39 | 0.92/H | 0.983 | 0.9445 | 0.972 | 0.949 | 1.0412 | 0.9682 | 6 | 0.010 | −1.25 | 0.620 | 0.91846 | 2nd | WFA5R7 |
25-αd-temp R9 | T3-36 | 0.96/H | 0.955 | 0.97 | 1.00 | 0.98 | 0.927 | 0.9670 | 7 | 0.180 | −1.30 | 0.560 | 0.90886 | 3rd | WFS6R7 |
31-αtαd-temp R9R14 | T4-38 | 0.94/H | 0.993 | 0.9495 | 0.985 | 0.952 | 0.9368 | 0.9594 | 10 | 0.028 | −1.20 | 0.586 | 0.90606 | 4th | WFR8 |
22-αd-temp | T4-30 | 0.95/H | 0.99 | 0.99 | 0.927 | 0.96 | 0.996 | 0.9688 | 5 | 0.070 | −1.12 | 0.525 | 0.90540 | 5th | KW |
22-αd-r-o-p A8I15 | T2-20 | 0.987/H | 0.977 | 0.976 | 0.863 | 0.906 | 0.9038 | 0.9353 | 0.007 | −1.39 | 0.692 | 0.90047 | 6th | tLyP-1 | |
29-βαd-PexS | T5-35 | 0.90/H | 0.995 | 0.985 | 0.83 | 0.995 | 0.9435 | 0.9414 | 21 | 0.054 | −1.34 | 0.643 | 0.89877 | 7th | MFC |
25-αd-temp | T3-9 | 0.97/H | 0.99 | 0.975 | 1.00 | 0.985 | 0.757 | 0.9461 | 19 | 0.170 | −1.35 | 0.590 | 0.89523 | 8th | WFR8 |
31-αtαd-temp R9R14 | T4-37 | 0.95/H | 0.9985 | 0.961 | 0.927 | 0.98 | 0.8538 | 0.9450 | 20 | 0.032 | −1.18 | 0.574 | 0.89200 | 9th | WFR8 |
22-αtαd-temp | T5-48 | 0.959/H | 1.00 | 0.7156 | 0.986 | 0.825 | 1.1563 | 0.9472 | 18 | 0.190 | −1.30 | 0.555 | 0.89119 | 10th | rP9a |
31-αtαd-mapegin-a2 | T3-50 | 0.881/L | 0.756 | 0.8295 | 0.967 | 0.983 | 0.9556 | 0.8953 | 0.077 | −1.81 | 0.867 | 0.89118 | 11th | TATa | |
25-αd-BMAP | T4-33 | 0.905/H | 0.991 | 0.9715 | 0.993 | 0.905 | 0.9868 | 0.9567 | 12 | 0.080 | −1.05 | 0.485 | 0.88931 | 12th | KW |
35-βtαd- PR-35a | T5-45 | 0.821/L | 0.994 | 0.6675 | 0.982 | 0.910 | 1.134 | 0.9180 | 0.012 | −1.44 | 0.714 | 0.88886 | 13th | whole | |
25-αd- temp L9V14 | T3-35 | 0.96/H | 0.999 | 0.97 | 1.00 | 0.98 | 0.978 | 0.9738 | 4 | 0.760 | −1.47 | 0.355 | 0.88540 | 14th | WFR8 |
28-αd-T2R1-L7S17-a2 | T4-32 | 0.93/H | 0.914 | 0.974 | 0.997 | 0.785 | 0.9557 | 0.9260 | 0.050 | −1.30 | 0.625 | 0.88300 | 15th | KT2W | |
25-αd-BMAP-18 | T4-25 | 0.90/H | 1.00 | 0.98 | 1.00 | 0.930 | 0.875 | 0.9475 | 17 | 0.090 | −1.01 | 0.460 | 0.87787 | 16th | KW |
27-αtβ d -temp V1R9 | T5-52 | 0.940/H | 0.992 | 0.974 | 0.963 | 0.960 | 0.888 | 0.9528 | 14 | 0.098 | −0.94 | 0.421 | 0.87684 | 17th | Sub 5 |
25-βαd-BMAP-a2 | T4-36 | 0.849/H | 0.987 | 0.9665 | 0.990 | 0.912 | 1.0828 | 0.9646 | 8 | 0.399 | −1.09 | 0.346 | 0.87616 | 18th | KW |
33-αd-adepantin-1A | T4-18 | 0.86/L | 1.00 | 0.955 | 1.00 | 0.98 | 0.8668 | 0.9436 | 0.630 | −1.56 | 0.465 | 0.87525 | 19th | WFR8 | |
25-αtβd-novispirin-a1 | T4-50 | 0.903/H | 0.959 | 0.9885 | 0.920 | 0.975 | 0.5942 | 0.8899 | 0.195 | −1.63 | 0.7175 | 0.87307 | 20th | KW | |
33-αd adepantin-1A-L15 | T4-51 | 0.878/L | 0.9995 | 0.9358 | 0.965 | 0.972 | 0.954 | 0.9506 | 16 | 0.826 | −1.63 | 0.402 | 0.87225 | 21 | WFR8 |
22-r-o-pA8I15 | T2-21 | 0.985/H | 0.98 | 0.962 | 0.683 | 0.91 | 0.960 | 0.9134 | 0.006 | −1.22 | 0.607 | 0.86963 | 22 | tLyPA3-1 | |
20-αβ BP100 | T4-34 | 0.927/H | 0.9975 | 0.9735 | 0.987 | 0.935 | 1.0426 | 0.9772 | 3 | 0.894 | −1.32 | 0.213 | 0.86803 | 23 | KW |
19-αβ BP33 | T4-9 | 0.93/H | 1.00 | 0.985 | 1.00 | 0.96 | 1.001 | 0.9793 | 2 | 0.820 | −1.19 | 0.185 | 0.86583 | 25 | KW |
28-αtα-novispirin-a1 | T3-38 | 0.94/H | 1.00 | 0.8745 | 0.995 | 0.978 | 0.9305 | 0.9526 | 15 | 0.551 | −1.17 | 0.310 | 0.86073 | 26 | WFL5R7 |
35-α adep1a | T4-17 | 0.80/L | 0.995 | 0.965 | 1.00 | 0.99 | 0.8552 | 0.9342 | 0.660 | −1.46 | 0.400 | 0.85789 | 29 | WFR8 | |
31-αtα mapegin-a1 | T3-49 | 0.958/H | 0.990 | 0.798 | 0.868 | 0.97 | 1.1887 | 0.9621 | 9 | 0.717 | −1.09 | 0.187 | 0.85127 | 30 | TAT |
18-αtα r-o-p-analog | T2-22 | 0.991/H | 1.00 | 0.962 | 0.97 | 0.795 | 0.61 | 0.8879 | 0.003 | −1.26 | 0.629 | 0.85091 | 31 | whole | |
25-α-BMAP2-18 | T4-52 | 0.961/H | 0.9995 | 0.988 | 0.948 | 0.955 | 0.6315 | 0.9139 | 0.176 | −1.09 | 0.457 | 0.84862 | 32 | KW | |
34-αtα-Zyk1a | T4-35 | 0.833/L | 0.9985 | 0.9815 | 0.983 | 0.987 | 0.9377 | 0.9534 | 13 | 0.938 | −1.33 | 0.196 | 0.84520 | 33 | WFR8 |
* The amphiphilic character of the peptide was assessed by the SPLIT 3.5 server (http://split.djpept.com/split/ accessed on 7 August 2022 [42]). Bold or normal font α, β, and t symbols are stronger or weaker predicted profiles of hydrophobic moments for helix, beta-strand, and turn secondary structure. The “d” symbol is for predominantly disordered structure when indicated by the flDPnn server [191] for the first 20 peptides. The same server predicts DNA and RNA binding sites for all 20 best peptides from 41% to 100% of their residues. Peptide’s abbreviations are in Table 2, Table 3, Table 4 and Table 5. For instance, the temp abbreviation stands for the L-K6V1 temporin 1CEb with the sequence IKKIVSKIKKLLK [112]. The a1 or a2 abbreviation is for analog1 or analog2. The single code letter with the subscript for the residue sequence position is used for substituted amino acids. In the asparagutin case (WFR8), R7 or R8 means the total number of arginines. # The peptide code number is “Tn-m” for “n” = 2,3,4,5, referring to the corresponding Table, and “m” for the peptide number in Table n. & Mean values of predicted probabilities for antimicrobial, anticancer, antiviral, and antifungal activity. See Table 2 for server addresses and corresponding references. We used the gray background to highlight cases among 20 best peptides when the probability for anticancer and antiviral activity is close to 1.0 (>0.95). $ Mean value of predicted scores by AIPpred, PreAIP, and AntiInflam servers. See Table 2 for server addresses and corresponding references. The AntiInflam server was included in the calculated mean for the cases when three or fewer amino acid substitutions were enough to raise the predicted score above 1.0 (except for the PR-35 analog with seven substitutions). † Peptides are first ranked (yellow background) regardless of their predicted hemolytic activity and toxicity. § Total score is calculated as: (CPP probability + mean antimicrobial probability + mean anti-cancer probability + mean antiviral probability + mean antifungal probability + mean anti-inflammatory score)/6 − (hemolytic activity probability + toxicity score)/2. The subtracted number is a positive reward for low toxicity. We used the blue and green background to rank the 20 best peptides according to their total score.